Trial Profile

Pivotal bioequivalence trial of glucagon, delivered by the Glucagon Emergency Management (GEM) system

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 20 Jan 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Glucagon (Primary)
Indications Hypoglycaemia
Focus Pharmacokinetics; Registrational
Sponsors Biodel

Most Recent Events

15 Dec 2014 New trial record
04 Dec 2014 This design of this trial and the comparator selected will be based on data from a phase I crossover trial in volunteers (clinical trial 700252270), according to a Biodel media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com